The expression of LRG1 is associated with a variety of malignancies, such as non-small-cell lung cancer (NSCLC) [1], ovarian cancer [2], and bladder cancer [3], and is thought to promote tumor growth via the angiogenesis process. This evidence concerns the gene LRG1 and non-small cell lung carcinoma.